Search research articles
Contact Us
Filters
Showing results (21-30 of 75) with videos related to
Page
of 8
Sort By:
Prostaglandins
|
May 1, 1983
Is prostaglandin F2 alpha involved in the increased myometrial contractility of primary dysmenorrhoea?
M A Lumsden, R W Kelly, D T Baird
Clinical Endocrinology
|
September 1, 1989
Tamoxifen prolongs luteal phase in premenopausal women but has no effect on the size of uterine fibroids
M A Lumsden, C P West, D T Baird
British Journal of Obstetrics and Gynaecology
|
February 1, 1992
Goserelin (Zoladex) in the treatment of fibroids
C P West, M A Lumsden, D T Baird
The Cochrane Database of Systematic Reviews
|
December 27, 2014
Uterine artery embolization for symptomatic uterine fibroids
Janesh K Gupta, Anju Sinha, M A Lumsden, et al.
The Cochrane Database of Systematic Reviews
|
May 18, 2012
Uterine artery embolization for symptomatic uterine fibroids
Janesh K Gupta, Anju Sinha, M A Lumsden, et al.
BJOG : an International Journal of Obstetrics and Gynaecology
|
June 17, 2004
Evaluation of the effect of uterine artery embolisation on menstrual blood loss and uterine volume
A Khaund, J G Moss, N McMillan, et al.
The Cochrane Database of Systematic Reviews
|
January 27, 2006
Uterine artery embolization for symptomatic uterine fibroids
J K Gupta, A S Sinha, M A Lumsden, et al.
Clinical Endocrinology
|
November 6, 2010
Vascular function and cardiovascular risk factors in women with severe flushing
J Sassarini, H Fox, W Ferrell, et al.
Climacteric : the Journal of the International Menopause Society
|
January 3, 2012
Hot flushes, vascular reactivity and the role of the α-adrenergic system
J Sassarini, H Fox, W Ferrell, et al.
BJOG : an International Journal of Obstetrics and Gynaecology
|
March 10, 2017
Vasomotor symptoms resulting from natural menopause: a systematic review and network meta-analysis of treatment effects from the National Institute for Health and Care Excellence guideline on menopause
G Sarri, H Pedder, S Dias, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 75) with videos related to
Sort By:
Page
of 8
Prostaglandins
|
May 1, 1983
Is prostaglandin F2 alpha involved in the increased myometrial contractility of primary dysmenorrhoea?
M A Lumsden, R W Kelly, D T Baird
Clinical Endocrinology
|
September 1, 1989
Tamoxifen prolongs luteal phase in premenopausal women but has no effect on the size of uterine fibroids
M A Lumsden, C P West, D T Baird
British Journal of Obstetrics and Gynaecology
|
February 1, 1992
Goserelin (Zoladex) in the treatment of fibroids
C P West, M A Lumsden, D T Baird
The Cochrane Database of Systematic Reviews
|
December 27, 2014
Uterine artery embolization for symptomatic uterine fibroids
Janesh K Gupta, Anju Sinha, M A Lumsden, et al.
The Cochrane Database of Systematic Reviews
|
May 18, 2012
Uterine artery embolization for symptomatic uterine fibroids
Janesh K Gupta, Anju Sinha, M A Lumsden, et al.
BJOG : an International Journal of Obstetrics and Gynaecology
|
June 17, 2004
Evaluation of the effect of uterine artery embolisation on menstrual blood loss and uterine volume
A Khaund, J G Moss, N McMillan, et al.
The Cochrane Database of Systematic Reviews
|
January 27, 2006
Uterine artery embolization for symptomatic uterine fibroids
J K Gupta, A S Sinha, M A Lumsden, et al.
Clinical Endocrinology
|
November 6, 2010
Vascular function and cardiovascular risk factors in women with severe flushing
J Sassarini, H Fox, W Ferrell, et al.
Climacteric : the Journal of the International Menopause Society
|
January 3, 2012
Hot flushes, vascular reactivity and the role of the α-adrenergic system
J Sassarini, H Fox, W Ferrell, et al.
BJOG : an International Journal of Obstetrics and Gynaecology
|
March 10, 2017
Vasomotor symptoms resulting from natural menopause: a systematic review and network meta-analysis of treatment effects from the National Institute for Health and Care Excellence guideline on menopause
G Sarri, H Pedder, S Dias, et al.
Page
of 8